Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SIRPG antibody

This anti-SIRPG antibody is a Mouse Monoclonal antibody detecting SIRPG in FACS. Suitable for Human.
Catalog No. ABIN2664296

Quick Overview for SIRPG antibody (ABIN2664296)

Target

See all SIRPG Antibodies
SIRPG (Signal-Regulatory Protein gamma (SIRPG))

Reactivity

  • 45
  • 7
  • 7
  • 3
  • 2
  • 1
Human

Host

  • 29
  • 15
  • 1
Mouse

Clonality

  • 29
  • 15
  • 1
Monoclonal

Conjugate

  • 27
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SIRPG antibody is un-conjugated

Application

  • 24
  • 18
  • 14
  • 8
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

LSB2-20
  • Purification

    The antibody was purified by affinity chromatography.

    Isotype

    IgG1 kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Target

    SIRPG (Signal-Regulatory Protein gamma (SIRPG))

    Alternative Name

    CD172g

    Background

    Signal Regulatory Proteins (SIRPs) comprise a family of several transmembrane glycoproteins (SIRPα, SIRPβ, and SIRPγ) that belong to immunoglobulin superfamily. SIRPγ is also known as CD172g or SIRPβ2 which is primarily expressed on T cells and a subpopulation of B cells. Like CD172a, the ligand of CD172g is CD47. But the binding affinity with CD172g is lower than CD172a. The biological functions of CD172g include regulation of T-cell transendothelial migration and induction of T cell apoptosis.
You are here:
Chat with us!